Navigation Links
Treatment for pre-menstrual syndrome is ineffective

The most commonly prescribed pre-menstrual syndrome (PMS) drugs are ineffective, research suggests. The majority of the 1.5 million women who suffer from PMS in the UK are prescribed progesterone or its synthetic equivalent, progestogens.

But a team of researchers from the University of Keele have found that taking progesterone no more effective than taking a placebo. The report said previous beliefs that PMS was caused by a progesterone deficiency were "unsubstantiated".//

Professor Shaughn O'Brien, head of Academic Obstetrics and Gynaecology at Keele who led the research, said the vast majority of women who suffer from the condition did not need to take drugs at all. 90% of women suffer from mild symptoms such as irritability. The team examined 14 studies on the effectiveness of the treatment, which has been routinely prescribed by doctors since the 1960s. They concluded that there was no "convincing evidence" to support the continued prescription of progesterone or progestogens to treat PMS.


'"/>




Page: 1

Related medicine news :

1. Advances in Treatment of Cataracts
2. Recommendations for Treatment of Blood Pressue
3. Treatment for Menieres disease
4. Better Treatment for obesity
5. Gene Treatment for Heart Disease
6. More People Seeking Treatment for Depression
7. Focused Treatment For Childhood Cancer
8. Inadequate Drug Treatment For Youth
9. FDA Approves New surgery Treatment for Farsightedness
10. Treatment of antibiotics ineffectual in bronchitis
11. Oxygen Treatment may be injurious
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2017)... , ... April 28, 2017 , ... The Texas Cord ... recently to the labor and delivery team at Women’s Hospital at Renaissance in Edinburg ... give birth at the hospital and decide to donate. , “Women’s Hospital at ...
(Date:4/28/2017)... ... April 28, 2017 , ... Early detection and ... drug safety and minimize the cost of development. In this webinar, sponsored by ... cell lines and for cardiac toxicity using induced pluripotent stem cells (iPSCs). , ...
(Date:4/28/2017)... ... 28, 2017 , ... Bill Howe started his sewer and drain company in ... Howe joined the team, the Bill Howe brand was born and they began cultivating ... giving back to the San Diego community in which they worked, lived and were ...
(Date:4/28/2017)... ... 2017 , ... Researchers at Moffitt Cancer Center ... Data Hub in a sample of participants enrolled in an ongoing cancer quality-of-life ... solutions for the global scientific community. The company’s new CentrePoint Data Hub is ...
(Date:4/28/2017)... ... April 28, 2017 , ... Intellitec Solutions announced the publication ... a Microsoft Dynamics GP solution that integrates to their PointClickCare EHR software package. ... long-term care, Brooke Grove now has the capability to achieve its goal for ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... -- Eyevensys, a private biotechnology company developing ... technology that enables the safe, local, sustained production of ... range of ophthalmic diseases, announces it has received approval ... (MHRA) to advance its technology into clinical development. ... The EyeCET platform ...
(Date:4/20/2017)... Research and Markets has announced the addition of ... By Service (Manufacturing, Research), By Country, (Brazil, Mexico, Colombia, Argentina, ... to their offering. ... The Latin American pharmaceutical contract manufacturing services market is anticipated ... drug registration cost in Latin American countries and continuous economic ...
(Date:4/19/2017)... -- Cardiology devices segment is anticipated to reach the highest ... Devices segment is likely to create absolute $ opportunity of ... 2017. By the end of 2027, Cardiology Devices segment is ... Mn, expanding at a CAGR of 18.4% over the forecast ... Pacific reprocessed medical devices market in terms of ...
Breaking Medicine Technology: